Cerity Partners’s Insulet PODD Stock Holding History

Cerity Partners’s Portfolio PODD Stock Details PODD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.48M	Buy	49,102 +13,113	+36%	+$2.18M	0.01%	901
2026 Q1	$7.55M	Buy	35,989 +22,783	+173%	+$5.73M	0.01%	829
2025 Q4	$3.75M	Buy	13,206 +679	+5%	+$212K	0.01%	1059
2025 Q3	$3.87M	Sell	12,527 -4,735	-27%	-$1.48M	0.01%	989
2025 Q2	$5.42M	Buy	17,262 +7,030	+69%	+$2.03M	0.01%	766
2025 Q1	$2.69M	Buy	10,232 +2,284	+29%	+$618K	0.01%	986
2024 Q4	$1.96M	Sell	7,948 -2,245	-22%	-$565K	﹤0.01%	1115
2024 Q3	$2.37M	Buy	10,193 +4,484	+79%	+$921K	0.01%	1015
2024 Q2	$1.15M	Buy	5,709 +2,171	+61%	+$391K	﹤0.01%	1161
2024 Q1	$606K	Buy	+3,538	New	+$660K	﹤0.01%	1511

Other funds holding PODD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Cerity Partners's PODD Position: Q2 2026 in Review

Cerity Partners increased its Insulet (PODD) stake by 36% in Q2 2026, buying an estimated $2.18M and bringing the position to 49,102 shares worth $7.48M. The position accounts for 0.01% of the portfolio, ranked #901.

Cerity Partners first reported a position in PODD in Q1 2024 and has held it in 10 quarters since. The position peaked at $7.55M in Q1 2026. 731 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

Cerity Partners held 49,102 shares of Insulet worth $7.48M as of Q2 2026.
Cerity Partners bought 13,113 Insulet shares in Q2 2026, an estimated $2.18M.
Insulet made up 0.01% of Cerity Partners's portfolio in Q2 2026, its #901 holding.
Cerity Partners first reported a position in Insulet in Q1 2024 and has held it in 10 quarters since.
Cerity Partners's Insulet position peaked at $7.55M in Q1 2026.
731 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.